Search clinical trials for: Glimepiride (HOE490)
Total 305 results
-
SanofiCompletedType 1 Diabetes MellitusUnited States, Puerto Rico
-
Rehab WeridaCompletedDiabetes Mellitus, Type 2Egypt
-
AstraZenecaCompletedType 2 Diabetes Mellitus | Inadequate Glycaemic ControlGermany, Slovakia, Czechia, Hungary, Poland
-
Merck Sharp & Dohme LLCCompleted
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesAustria, Hungary, Slovenia, Germany, Czech Republic, Poland, Slovakia
-
Damanhour UniversityTanta UniversityCompletedCoronary Artery Disease | Diabetes Mellitus, Type 2Egypt
-
GRADE Study GroupBristol-Myers Squibb; National Institute of Diabetes and Digestive and Kidney... and other collaboratorsCompletedType 2 Diabetes | Comparative Effectiveness of Glycemia-lowering MedicationsUnited States
-
Boehringer IngelheimCompletedDiabetes Mellitus, Type 2United States, Bulgaria, Denmark, France, Germany, Hong Kong, Hungary, India, Ireland, Italy, Netherlands, Norway, Poland, South Africa, Sweden, United Kingdom
-
Brigham and Women's HospitalCompleted
-
Haukeland University HospitalUnknownInsulin-dependent Diabetes Mellitus | Maturity-Onset Diabetes of the Young, Type 3 | Maturity Onset Diabetes of the Young, Type 1 | Childhood Diabetes MellitusNorway
-
Eli Lilly and CompanyCompletedType 2 Diabetes MellitusChina, Korea, Republic of, Taiwan
-
Kyunghee University Medical CenterTakeda; Korea University Guro Hospital; Ajou University School of Medicine; Kangbuk... and other collaboratorsUnknownDiabetesKorea, Republic of
-
SanofiCompletedType 2 Diabetes MellitusChina, Taiwan, Korea, Republic of
-
University of JordanCompletedDiabetes Mellitus, Type 2Jordan
-
SanofiCompletedDiabetes Mellitus, Type 2Jordan
-
AstraZenecaCompleted
-
Eli Lilly and CompanyWithdrawnDiabetes Mellitus, Type 2United States, Spain, Poland, Austria, Germany, Czech Republic, Russian Federation
-
Yonsei UniversityRecruitingDiabetes Mellitus | Sodium-Glucose Transporter 2 Inhibitors | Cellular SenescenceKorea, Republic of
-
Astellas Pharma IncCompleted
-
SanofiCompletedType 2 Diabetes MellitusCanada
-
SanofiCompletedType 1 Diabetes MellitusGermany
-
Vanderbilt UniversityCompleted
-
Merck Sharp & Dohme LLCCompleted
-
SanofiCompleted
-
SanofiCompletedType 1 Diabetes MellitusGermany
-
Kaiser PermanentePatient-Centered Outcomes Research Institute; Henry Ford Health System; HealthPartners... and other collaboratorsRecruitingCardiovascular Diseases | Type 2 Diabetes MellitusUnited States
-
PfizerCompletedDiabetes Mellitus, Type 2Taiwan, United States, Hungary, Canada, Slovakia, India, Bulgaria
-
SanofiCompletedDiabetes Mellitus, Type 2France
-
Yonsei UniversityCompletedType2 Diabetes MellitusKorea, Republic of
-
Hannover Medical SchoolBoehringer IngelheimTerminated
-
SanofiCompleted
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, Argentina, Austria, Canada, Colombia, Czech Republic, Finland, Hong Kong, India, Italy, Malaysia, Mexico, Netherlands, Norway, Philippines, Portugal, South Africa, Spain, Sweden, Switzerland, Taiwan, Thailand, United...
-
Boehringer IngelheimCompleted
-
SanofiCompletedType 2 DiabetesUnited States, Australia, Canada, Chile, Czech Republic, Denmark, Estonia, Hungary, Lithuania, Mexico, Netherlands, Poland, Romania, Russian Federation, Slovakia, Spain, Sweden, Ukraine
-
University Hospital, Gentofte, CopenhagenNovo Nordisk A/S; University of CopenhagenCompletedMaturity-onset Diabetes of the YoungDenmark
-
SanofiCompletedType I Diabetes MellitusBrazil
-
VA Office of Research and DevelopmentNational Eye Institute (NEI); SmithKline BeechamCompletedType 2 Diabetes MellitusUnited States, Puerto Rico
-
SanofiCompletedType 2 DiabetesAustralia, Denmark, South Africa, Spain, Belgium, Russian Federation, Canada, Estonia, Hungary, Latvia, Mexico, United States, Chile, Czech Republic, France, Germany, Italy, Lithuania, Poland, Romania, Sweden, Ukraine, United Kingdom
-
Kurume UniversityUnknownEffects of the DPP-4 Inhibitors or SGLT2 Inhibitors on the Protective Actions for Diabetic ComplicationsJapan
-
SanofiCompleted
-
SanofiCompleted
-
SanofiCompleted
-
Gulf Regional Research & Educational Services, LLCUnknownMechanistic Study of the Systolic Blood Pressure Lowering Effect of Dapagliflozin in Type 2 DiabetesDiabetes Mellitus Type 2United States
-
Peking Union Medical College HospitalChinese Academy of SciencesUnknown
-
SanofiActive, not recruiting
-
Merck Sharp & Dohme LLCCompleted
-
SanofiCompletedType 2 Diabetes MellitusGermany, United Kingdom
-
University of MichiganAstraZenecaCompletedCardiovascular Diseases | Type2 DiabetesUnited States